Key result
Novel variants in the CLCN6 gene within the MTHFR-CLCN6-NPPA-NPPB cluster were independently associated with increased NT-proBNP levels, with a dosage effect of 20-100 pg/ml for two haplotype copies.
Why the study?
Are genetic variants in the MTHFR-CLCN6-NPPA-NPPB gene cluster associated with NT-proBNP levels in the general population?
Observational (n=3,071)
Yes
Are genetic variants in the MTHFR-CLCN6-NPPA-NPPB gene cluster associated with NT-proBNP levels in the general population?
p-value: p=8.4 × 10(-10)
Genetic variants in the CLCN6 gene within the MTHFR-CLCN6-NPPA-NPPB cluster are independently associated with increased NT-proBNP levels, providing insights into the biological mechanisms of cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
No clinical implications for NT-proBNP interpretation; leaves open CLCN6 functional roles in population cardiac biomarker genetics.
M et al. (2011) conducted an observational in Cardiac dysfunction (n=3,071). Genetic variants in the MTHFR-CLCN6-NPPA-NPPB gene cluster was evaluated on NT-proBNP level (p=8.4 × 10(-10)). Novel variants in the CLCN6 gene within the MTHFR-CLCN6-NPPA-NPPB cluster were independently associated with increased NT-proBNP levels, with a dosage effect of 20-100 pg/ml for two haplotype copies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: